Drug Shortage Report for AURO-ARIPIPRAZOLE
Report ID | 171268 |
Drug Identification Number | 02460076 |
Brand name | AURO-ARIPIPRAZOLE |
Common or Proper name | ARIPIPRAZOLE |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | ARIPIPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30's |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-10-07 |
Estimated end date | 2023-07-30 |
Actual end date | 2023-06-12 |
Shortage status | Resolved |
Updated date | 2023-06-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-06-28 | French | Compare |
v8 | 2023-06-28 | English | Compare |
v7 | 2023-06-28 | French | Compare |
v6 | 2023-06-28 | English | Compare |
v5 | 2023-05-29 | French | Compare |
v4 | 2023-05-29 | English | Compare |
v3 | 2023-04-25 | French | Compare |
v2 | 2023-04-25 | English | Compare |
v1 | 2022-10-07 | English | Compare |
Showing 1 to 9 of 9